Menachem Kranz

Menachem focuses on medical and healthcare technology. He has 20 years’ experience in the securities and finance industry, most recently as Founder and Portfolio Manager of Ahava Investment Partners where he meaningfully outperformed its benchmark index over a 5-year period. Prior to Ahava, Menachem was a Managing Partner of the merchant bank Littlebanc Advisors, and a VP of Investment Banking at Ladenburg Thalmann & Co., raising capital for emerging life sciences and technology companies.

​Prior to joining Ladenburg, Menachem leveraged his extensive contacts and relationships with institutional investors in a variety of contexts, including as a hybrid trader with RBC Capital Markets and a Senior VP of institutional research sales at Avalon Research Group. There, he was instrumental in the rapid growth and development of the firm. He has built an extensive information network of contacts and relationships covering both public and private companies.

Menachem is a graduate of the Rabbinical College of America. He serves on Wilmington Capital Securities’ Equity Capital Life Sciences Division and holds FINRA series 7 and 63 licenses.​